Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections
about
Bacterial infections in cirrhosis: A critical review and practical guidanceResponse to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 hInflammatory status in human hepatic cirrhosisClinical characteristics and prognostic impact of bacterial infection in hospitalized patients with alcoholic liver disease.Mean platelet volume as a novel predictor of systemic inflammatory response in cirrhotic patients with culture-negative neutrocytic ascites.The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosisAttenuated antigen-specific T cell responses in cirrhosis are accompanied by elevated serum interleukin-10 levels and down-regulation of HLA-DR on monocytesBloodstream infections in patients with liver cirrhosis.Procalcitonin and C-reactive protein in the diagnosis and prediction of spontaneous bacterial peritonitis associated with chronic severe hepatitis BPresepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.Disease dependent qualitative and quantitative differences in the inflammatory response to ascites occurring in cirrhoticsProcalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites.Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis.Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections.Bacterial translocation markers in liver cirrhosis.Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections.High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis.Macrophage activation marker, soluble CD163 is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.Diagnostic Accuracy of Serum Procalcitonin for Spontaneous Bacterial Peritonitis Due to End-stage Liver Disease: A Meta-analysis.Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children.C-reactive protein and bacterial infection in cirrhosis.Acute phase proteins in patients with cirrhosis.Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein.Reply to the diagnostic conundrum of bacterial infections in cirrhotic patients.Bacterial Infection and Predictors of Mortality in Patients with Autoimmune Liver Disease-Associated Acute-On-Chronic Liver Failure.Cytokeratin 18-based cell death markers indicate severity of liver disease and prognosis of cirrhotic patients.Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation.Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directionsManagement of Infectious Complications Associated with Acute-on-Chronic Liver FailureMajor Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute DecompensationCombination of PCT, sNFI and dCHC for the diagnosis of ascites infection in cirrhotic patients
P2860
Q26766663-2965AC2A-C471-431C-B8FF-4D8E953E9032Q26770382-012476A1-87A6-4ABA-957E-D7E58477286AQ26778040-FD9DF029-B80F-4FA8-8009-EB8D16D87DF6Q35553704-5116C84B-BB1D-469B-987E-910C9246845DQ35567734-CE18AFC6-7A05-40EA-8967-B0895002E1E7Q35820519-17675973-E3E2-4E9A-AFF6-0E22AFFB1DBDQ36687405-D57C3734-FB07-466C-8D25-D5BF0DC6DD0BQ36913304-A3D549FC-17D4-4FF5-BB81-0ACCA703ABB4Q37284988-3A897107-369D-47BE-9B7E-392BDCCB470AQ37411315-359F2324-1DAB-4930-A175-C73EB51DA5A1Q37603064-9DB1E84F-9800-4A36-A72C-B330D8D08FD3Q37617986-6FD76C6B-F8DF-426F-8CBE-2284C221E680Q38637305-80F4C4B6-EE12-4AD2-BEAE-A24711F20C31Q40074799-5663A874-6E37-4B5C-9CA9-ABF9AB1A73C1Q40078218-E85D8B74-DF02-4973-B193-D5CBF53A48EAQ40363376-46E22DF5-8F64-4327-9F53-AB32214264FFQ40476379-DCE722EA-43AD-4032-B50C-736D0F575B02Q40734458-806FA308-6475-4966-B00C-558505F2F991Q40875663-7A0A6B5B-08BC-4DF0-9954-8E94D5A5A59BQ41575386-E05B4B81-FD27-4AE0-979A-D39281A3B26AQ42360902-FBE34BEC-1691-49CA-802C-F42B937F6947Q43467777-A5793E1F-B467-4828-AE87-DE43E324FDEAQ47431015-A1CA1526-751E-4B7F-8182-05DAC405D60DQ48169566-1AB17FC6-698D-4C81-9E96-8FF418BAC3EFQ52603513-7D68ED5D-A1B3-44E4-B4AF-A7A8B9564C7BQ54634837-E27E564F-3E24-4C5D-A1CD-2EF0071928B3Q54957028-338AE9D5-A855-4484-8AAF-5A13306C8F5DQ57815117-CCC52C5A-0A67-46C7-B9BE-50F539E7ABF6Q57824689-3546BCA4-7F28-4BDE-BF28-E90F97DE5594Q58481395-B4AA6F67-2B14-42D7-9389-C941D5F3AD46Q58791538-A6E0344E-CB57-48A8-947E-E679B172CB2D
P2860
Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections
description
im Dezember 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2011
@uk
name
Acute phase proteins in the di ...... ssociated bacterial infections
@en
Acute phase proteins in the di ...... ssociated bacterial infections
@nl
type
label
Acute phase proteins in the di ...... ssociated bacterial infections
@en
Acute phase proteins in the di ...... ssociated bacterial infections
@nl
prefLabel
Acute phase proteins in the di ...... ssociated bacterial infections
@en
Acute phase proteins in the di ...... ssociated bacterial infections
@nl
P2093
P2860
P1433
P1476
Acute phase proteins in the di ...... ssociated bacterial infections
@en
P2093
Andras Vida
Istvan Altorjay
Istvan Tornai
Janos Kappelmayer
Maria Papp
Miklos Udvardy
Peter Antal-Szalmas
Zsuzsanna Vitalis
P2860
P304
P356
10.1111/J.1478-3231.2011.02689.X
P577
2011-12-06T00:00:00Z